RADIOPHARMACEUTICAL SCIENCES (RS)
Coordinator: Dr. António Rocha Paulo
Thematic Strand: Radiopharmaceutical Sciences and Health Physics (RSHP)
MISSION and OBJECTIVES
The multidisciplinary team of the Radiopharmaceutical Sciences Group (RSG) develops fundamental and applied research activities on the design and preclinical evaluation of radioactive probes for Molecular Imaging by PET or SPECT and Targeted Radionuclide Therapy, in tune with the priorities of the Portuguese Science Foundation (FCT) that considered “Diagnostic, Therapy and Public Health” an important topic in the Life Sciences and Health domain. During the past few years, the RSG has been mainly devoted to the development and evaluation of molecular/nanosized tools for a theranostic approach to cancer, based on PET (64Cu, 68Ga) and SPECT (99mTc, 67Ga, 111In) radiometals and on beta- (188Re, 153Sm, 166Ho) or Auger-emitting (125I) therapeutic radionuclides. In this way, the RSG aims to contribute for the rise of molecular and personalized medicine, an area where nuclear imaging and radionuclide therapy are assuming greater importance.